Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
about
Application of appropriate use criteria for percutaneous coronary intervention in JapanIvabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.The management of thyroid nodules: a retrospective analysis of health insurance dataThe impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease.Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based studyChanges in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflationAchievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).Shared decision making in patients with stable coronary artery disease: PCI choice.Appropriate revascularization in stable angina: lessons from the BARI 2D trial.Practice patterns and trends in the use of medical therapy in patients undergoing percutaneous coronary intervention in Ontario.Improving guidelines for the management of coronary heart disease risk factorsAppropriateness of percutaneous coronary interventionCardiovascular risk management with liaison critical path in Japan: its effects on implementation of evidence-based prevention in practice.Risk of Stroke in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention versus Optimal Medical Therapy: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Effects of statin treatment in patients with coronary artery disease and chronic kidney diseaseTrends in PCI volume after negative results from the COURAGE trialImpact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020.Predictors of statin adherence.The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease.Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.Medical management of stable coronary atherosclerosis.Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice.Almanac 2013: stable coronary artery disease.Almanac 2013: stable coronary artery disease.Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease.Predictors of Medical Management in Patients Undergoing Elective Cardiac Catheterization for Chronic Ischemic Heart Disease.Quality of medical management in coronary artery disease.Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices.Why Optimal Medical Therapy Should Be a Universal Standard of Care.Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint.Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease.
P2860
Q28070382-78DE4331-A217-48C5-8202-7AFF42CEF509Q30316766-4B5E43DE-B3B4-49BD-A566-1D157D371986Q30719474-42BB5D00-01E1-4157-A24E-EEFC56571D13Q33615444-8707850B-EB76-47E8-A7BF-9DC9E407E201Q33770249-0566AB59-A649-4830-952A-4747CA43CF0AQ34198543-A70D66DE-2CDC-4E94-B714-34C4B1C83D7FQ34364029-2730D74C-7A1D-4A0C-A0B9-80E0CA189EBDQ34505058-9F206EE5-9236-40E8-9028-E45FF8F4D412Q34696317-EAD0E9C6-C38A-40F6-A576-EF2D5B1E85B9Q35026227-1C426344-942A-4092-9636-E729AFAAC166Q35691338-D6D0A3B3-7368-4D52-8621-AE4F53040BF3Q35800916-63B192D2-08D7-4099-9FE7-20D0BB7D9D40Q35872481-B64F18AC-5A4D-4A30-ACEB-21A84CEFBA04Q36071090-EC6D65E7-1096-4E64-A5D9-56181F42C58CQ36787252-DC632FBD-0B13-47A9-8D2F-E64CC6B33619Q37254899-CF549DC9-6CA2-48D1-8CFD-D94527343A74Q37471756-0ACE91BA-513F-4DA8-82C2-DCF965A30C2EQ37580425-0EA1FE56-C69C-418D-9204-7B21F424AAFBQ37628382-50459B1C-6AE7-4E03-B1AF-66BD1E1F5308Q37928904-E16311F7-ECBB-4145-884D-5C83E345FD52Q37938836-3AE83404-B7F2-4D16-A221-431ED9278624Q38006739-56A95548-E142-4CCC-81E5-03C322A3065EQ38007395-F21FEE21-DAF5-4B20-934A-3065D638D141Q38083007-2F14B5AB-92CF-4412-9F96-6C4AF18F596FQ38124877-D43341FB-3CEE-4732-A9C6-2A3DAA72846BQ38134684-20E197BC-C5B6-47A3-A07D-2D2EC492C17EQ38168109-1DE56BF8-70C4-4E6D-A724-8290E02CEEDCQ38382538-548C4C83-708F-4123-BDF1-712C8B36F2D8Q38388236-F432BCFE-1435-4650-A8E2-E801C86D5218Q38589870-0338C9FF-D929-46F5-8C4B-E537B7A96E3BQ39249132-CD851791-7191-451E-8C0A-93C6210C39D6Q40406188-AB9066F0-0129-4EDF-AC80-CD484059161DQ40928026-B6497162-AAAC-4050-8A0A-53990AF41066Q40942474-BE38358B-90D2-4052-ABE9-200C0771F1FDQ42361724-69BCDE15-E431-49EE-8C7F-0494F892CAB4Q42742549-2E05D3C8-08E1-40BB-A573-00BA81790F48Q43111963-A4C183A5-D272-48B7-8371-1BE761CCF860Q43722663-298AE985-CB2D-410A-86FE-0A41A922C374Q47151397-94780A2C-7B54-4955-A866-5348C7F37F7BQ47687627-2E695B7F-D75C-49C7-ACDC-982E348F18FF
P2860
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Patterns and intensity of medi ...... taneous coronary intervention.
@en
Patterns and intensity of medi ...... taneous coronary intervention.
@nl
type
label
Patterns and intensity of medi ...... taneous coronary intervention.
@en
Patterns and intensity of medi ...... taneous coronary intervention.
@nl
prefLabel
Patterns and intensity of medi ...... taneous coronary intervention.
@en
Patterns and intensity of medi ...... taneous coronary intervention.
@nl
P2093
P356
P1476
Patterns and intensity of medi ...... taneous coronary intervention.
@en
P2093
Alvin I Mushlin
Lisa A Kaltenbach
Rita F Redberg
William B Borden
P304
P356
10.1001/JAMA.2011.601
P407
P577
2011-05-01T00:00:00Z